InvestorsHub Logo
Followers 0
Posts 350
Boards Moderated 1
Alias Born 07/28/2023

Re: Yooperman post# 64258

Tuesday, 05/07/2024 10:07:24 AM

Tuesday, May 07, 2024 10:07:24 AM

Post# of 64786
It is just a matter of time huh? You have been saying that for a long time (and there has almost always been an opportunity to buy lower while waiting on that unlikely/ill-defined prospect).

Would any of the pumpers care to try and explain how an early bio that has existed for more than a decade (and not completed a single registered clinical trial), has more than 2 M in debt, is burning through more than 2M a year in operating costs, has less than 30K cash on hand, is on pace to dilute ~2.5 BILLION shares a year, has sales of less than 100K (which are declining), and has no registered clinical trials even started (let alone completed) beyond P1 is going to stay solvent and get to real commercialization?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TSOI News